Indaptus Therapeutics, INC Form 4 insider transactions

Mark John Gilbert, a director of Indaptus Therapeutics, acquired stock options exercisable for 12,500 shares of common stock.

Director Roger Pomerantz acquired 30,000 stock options in Indaptus Therapeutics on June 6, 2024.

Director Anthony Maddaluna reports acquisition of stock options in Indaptus Therapeutics.

Robert Martell, a director of Indaptus Therapeutics, acquired stock options exercisable for 12,500 shares of common stock on June 6, 2024.

Director William B. Hayes acquired 12,500 stock options in Indaptus Therapeutics on June 6, 2024.